Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
611820 | mTOR-IN-1 | 1207358-59-5 | 98% | |
mTOR-IN-1 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 1.5 | ||||
161009023 | Miltefosine | 58066-85-6 | 98% by HPLC | |
Miltefosine targets cellular membranes, modulating cell membrane permeability, membra | ||||
169701 | 1-METHYL-5-NITRO-1H-INDOLE | 29906-67-0 | 98% by HNMR/HPLC | |
1-METHYL-5-NITRO-1H-INDOLE CAS#29906-67-0 | ||||
16071022 | Mubritinib | 366017-09-6 | 98% by HPLC | |
Mubritinib, also known as TAK-165, is a protein kinase inhibitor which was under deve | ||||
16070814 | MK-8245 | 1030612-87-3 | 98% by HPLC | |
MK-8245 | ||||
16070813 | MLN120B | 783348-36-7 | 98% by HPLC | |
MLN120B | ||||
16070106 | MS417 | 916489-36-6 | 98% by HPLC | |
MS417, also known as GTPL7512, is a potent and selective BRD4 inhibitor. MS417 inhibi | ||||
16062901 | Molidustat (BAY85-3934) | 1154025-82-6 | 98% by HPLC | |
Molidustat (BAY85-3934) | ||||
1662118 | MK-8931 ( Verubecestat ) | 1286770-55-5 | 98% by HPLC/HNMR | |
Verubecestat(MK-8931) is a small-molecule inhibitor of beta-secretase cleaving enzyme | ||||
16062101 | Methyl 2,5-dimethylnicotinate | 63820-72-4 | 98% by HPLC | |
Methyl 2,5-dimethylnicotinate | ||||
16060603 | MDK-5220 | 1796565-52-0 | 98% by HPLC | |
MDK-5220 exhibits an orexin agonist activity and is expected to be useful as an excel | ||||
032514 | MK-5172 | 1350514-68-9 | 98% | |
Coming soon! | ||||
030904 | Mirodenafil | 862189-95-5 | 98% | |
Coming soon! | ||||
030901 | MK-2866 | 1202044-20-9 | 98% | |
Coming soon! | ||||
030101 | MCC950 | 210826-40-7 | 98% | |
MCC950 is a potent, selective, small-molecule inhibitor of NLRP3 with IC50 of 7.5 nM | ||||
020106 | MRE-269 | 475085-57-5 | 98% | |
MRE-269 is a long-acting and highly selective prostacyclin receptor agonist. | ||||
011906 | MSX-122 | 897657-95-3 | 98% | |
MSX-122 is a n orally bioavailable inhibitor of CXCR4 with potential antineoplastic a | ||||
011902 | ME-143 | 852536-39-1 | 98% | |
ME -143 is a derivative of triphendiol and is a highly potent, pan acting ant-cancer. | ||||
011805 | MK-2206 | 1032349-93-1 | 98% | |
MK-2206 2Hcl is an orally bioavailable allosteric inhibitor of the serine/threonine p | ||||
011801 | MK-8033 | 1001917-37-8 | 98% | |
MK8033 is a novel and specific dual ATP competitive c-Met/Ron inhibitor (IC50=1 nM Wt | ||||
011301 | ML324 | 1222800-79-4 | 98% | |
ML324 is a potent JMJD2 demethylase inhibitor with demonstrated antiviral activity. | ||||
011110 | MK-1775 | 955365-80-7 | 98% | |
MK-1775 is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM; hinders G2 DNA | ||||
010806 | MK-2461 | 917879-39-1 | 98% | |
MK-2461 is a novel ATP-competitive multitargeted inhibitor of activated c-Met. | ||||
010606 | Medetomidine hydrochloride | 86347-15-1 | 98% | |
Medetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is use | ||||
010424 | MK-2048 | 870005-19-9 | 98% | |
MK-2048 is a second generation integrase inhibitor, intended to be used against HIV i | ||||
51627 | MK7622 | 1227923-29-6 | 98% by HPLC | |
MK-7622isused as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for t | ||||
123007 | MK-4827 | 1038915-60-4 | 98% | |
MK-4827 is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM; with grea | ||||
122949 | MK-0752 | 471905-41-6 | 98% | |
MK-0752 is a moderately potent -secretase inhibitor, which reduces A40 production wit | ||||
122819 | MK8745 | 885325-71-3 | 98% | |
MK-8745 is a novel Aurora-A specific inhibitor. MK8745 induced apoptotic cell death i | ||||
122217 | MK 886 | 118414-82-7 | 98% | |
MK 886 is a leukotriene antagonist. It may perform this by blocking the 5-lipoxygenas |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1